Le Lézard
Classified in: Health
Subjects: PDT, WOM

Ditch the Squish: Solis Mammography Offers 93 Percent More Comfort During Mammograms with SmartCurvetm Technology


DALLAS, Sept. 10, 2018 /PRNewswire/ -- Solis Mammography, the nation's leader in breast imaging, is declaring September Breast Wellness Month and encouraging every woman to #DitchTheSquish with the launch of SmartCurvetm technology in its 50+ centers across the country. Building on more than 30 years of expertise, Solis Mammography is the largest provider of SmartCurve technology, a revolutionary new breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.

Stephen Rose, M.D., Solis Mammography's director of clinical research, was one of the pioneers, in partnership with Hologic, to develop the SmartCurvetm technology. 

"For decades, Solis Mammography has been shaping the future of mammograms in both the imaging technology innovation, as well as the entire experience for women," said Rose. "We're celebrating women this month by launching SmartCurve technology in all of our centers nationwide. We're continually thinking ahead of the curve to deliver the best breast wellness experience for women. And we're activating the conversation around the topic through our Every Woman campaign to offer women a safe platform to talk about breast health and body image as part of their self-care regimen."

SmartCurve technology provides a more comfortable experience that integrates 3D technology for even greater accuracy. SmartCurve technology has a curved compression surface that mirrors the shape of a woman's breast for ultimate comfort and accuracy. This revolutionary technology improves the patient experience by 93 percent, reduces calls back for negative-positives up to 40 percent and detects an average of 48 percent more invasive breast cancers.

Since the invention of the mammogram in 1960, women have been subjected to rudimentary technology that bent toward practicality and neglected the female form. They have been advised by their physicians to get their annual mammogram as a sterile, standard test, instead of a vital, self-care regimen. Solis Mammography is empowering women to embrace the new technology that now echoes their shape and to step up as breast wellness advocates to take control of their breast health by:

Find a center with SmartCurve mammography
With more than 50 centers, Solis Mammography serves patients across North Texas; Houston, Texas; Phoenix, Arizona; Columbus, Ohio; Greensboro, North Carolina, Philadelphia, Pennsylvania; and, through our affiliated brand Washington Radiology, Washington, D.C., Maryland and Virginia. Learn more about Solis Mammography, www.solismammo.com. Our centers promise:

About Solis Mammography
The nation's largest independent provider of breast screening and diagnostic services, Solis Mammography has been dedicated to helping women achieve and maintain breast health and peace of mind for more than 30 years and more than 5 million procedures. As a pioneer and innovator in 3D mammography and as an architect and early advocate for SmartCurve, Solis Mammography has stayed at the forefront of breast health by continuing to deliver a better experience and a more accurate mammogram to the generations of women we serve.

For more information, visit SolisMammo.com, like us on Facebook, follow us on Instagram and Twitter and subscribe to our YouTube channel.

 

SOURCE Solis Mammography


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: